These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Source of the increased serum alkaline phosphatase activity in Paget's disease. Sussman HH. Clin Chim Acta; 1970 Jan; 27(1):121-4. PubMed ID: 5412593 [No Abstract] [Full Text] [Related]
6. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity. Alvarez L, Peris P, Pons F, Guañabens N, Herranz R, Monegal A, Bedini JL, Deulofeu R, Martínez de Osaba MJ, Muñoz-Gómez J, Ballesta AM. Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934 [Abstract] [Full Text] [Related]
7. Office management of Paget's disease. Lender M, Menczel J. Geriatrics; 1981 May; 36(5):105-12. PubMed ID: 7215807 [No Abstract] [Full Text] [Related]
8. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. Garnero P, Delmas PD. J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954 [Abstract] [Full Text] [Related]
9. Paget's disease of bone: a review of 889 patients. Davie M, Davies M, Francis R, Fraser W, Hosking D, Tansley R. Bone; 1999 May; 24(5 Suppl):11S-12S. PubMed ID: 10321918 [No Abstract] [Full Text] [Related]
11. Treatment of Paget's disease with a diphosphonate (sodium etidronate). Smith R, Russell RG. Semin Drug Treat; 1972 May; 2(1):77-81. PubMed ID: 4558759 [No Abstract] [Full Text] [Related]
14. Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial. Reid IR, Nicholson GC, Weinstein RS, Hosking DJ, Cundy T, Kotowicz MA, Murphy WA, Yeap S, Dufresne S, Lombardi A, Musliner TA, Thompson DE, Yates AJ. Am J Med; 1996 Oct; 101(4):341-8. PubMed ID: 8873503 [Abstract] [Full Text] [Related]